Epigenetics in Cardiovascular Disease

$120.00

Epigenetics in Cardiovascular Disease

by Yvan Devaux (Editor), Emma Louise Robinson (Editor)

Epigenetics in Cardiovascular Disease, a new volume in the Translational Epigenetics series, offers a comprehensive overview of the epigenetics mechanisms governing cardiovascular disease development, as well as instructions in research methods and guidance in pursing new studies. More than thirty international experts provide an (i) overview of the epigenetics mechanisms and their contribution to cardiovascular disease development, (i) high-throughput methods for RNA profiling including single-cell RNA-seq, (iii) the role of nucleic acid methylation in cardiovascular disease development, (iv) epigenetic actors as biomarkers and drug targets, (v) and the potential of epigenetics to advance personalized medicine. Here, readers will discover strategies to combat research challenges, improve quality of their epigenetic research and reproducibility of their findings. Additionally, discussion of assay and drug development for personalized healthcare pave the way for a new era of understanding in cardiovascular disease.

  • Offers a thorough overview of role of epigenetics mechanisms in cardiovascular disease
  • Includes guidance to improve research plans, experimental protocols design, quality and reproducibility of results in new epigenetics research
  • Explores biomarkers and drug targets of therapeutic potential to advance personalized healthcare
  • Features chapter contributions from a wide range of international researchers in the field

Description

Epigenetics in Cardiovascular Disease

by Yvan Devaux (Editor), Emma Louise Robinson (Editor)

Epigenetics in Cardiovascular Disease, a new volume in the Translational Epigenetics series, offers a comprehensive overview of the epigenetics mechanisms governing cardiovascular disease development, as well as instructions in research methods and guidance in pursing new studies. More than thirty international experts provide an (i) overview of the epigenetics mechanisms and their contribution to cardiovascular disease development, (i) high-throughput methods for RNA profiling including single-cell RNA-seq, (iii) the role of nucleic acid methylation in cardiovascular disease development, (iv) epigenetic actors as biomarkers and drug targets, (v) and the potential of epigenetics to advance personalized medicine. Here, readers will discover strategies to combat research challenges, improve quality of their epigenetic research and reproducibility of their findings. Additionally, discussion of assay and drug development for personalized healthcare pave the way for a new era of understanding in cardiovascular disease.

  • Offers a thorough overview of role of epigenetics mechanisms in cardiovascular disease
  • Includes guidance to improve research plans, experimental protocols design, quality and reproducibility of results in new epigenetics research
  • Explores biomarkers and drug targets of therapeutic potential to advance personalized healthcare
  • Features chapter contributions from a wide range of international researchers in the field

Reviews

There are no reviews yet.

Be the first to review “Epigenetics in Cardiovascular Disease”

Your email address will not be published. Required fields are marked *

Title